{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T04:18:19Z","timestamp":1793852299034,"version":"4.6.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T00:00:00Z","timestamp":1607558400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T00:00:00Z","timestamp":1607558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1038\/s41401-020-00571-7","type":"journal-article","created":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T04:07:25Z","timestamp":1607573245000},"page":"1449-1460","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["3,4-dihydroxytoluene, a metabolite of rutin, suppresses the progression of nonalcoholic fatty liver disease in mice by inhibiting p300 histone acetyltransferase activity"],"prefix":"10.1038","volume":"42","author":[{"given":"Jangho","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Hye","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Yu","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Hyuk","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-Gyu","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Ho","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Taek","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyo-Kyoung","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,10]]},"reference":[{"key":"571_CR1","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.semcancer.2016.04.002","volume":"40\u201341","author":"E Shankar","year":"2016","unstructured":"Shankar E, Kanwal R, Candamo M, Gupta S. Dietary phytochemicals as epigenetic modifiers in cancer: promise and challenges. Semin Cancer Biol. 2016;40\u201341:82\u201399.","journal-title":"Semin Cancer Biol"},{"key":"571_CR2","doi-asserted-by":"publisher","first-page":"4079","DOI":"10.3748\/wjg.v22.i16.4079","volume":"22","author":"H Fotbolcu","year":"2016","unstructured":"Fotbolcu H, Zorlu E. Nonalcoholic fatty liver disease as a multi-systemic disease. World J Gastroenterol. 2016;22:4079\u201390.","journal-title":"World J Gastroenterol"},{"key":"571_CR3","doi-asserted-by":"publisher","first-page":"5161","DOI":"10.3390\/ijms16035161","volume":"16","author":"C Sun","year":"2015","unstructured":"Sun C, Fan JG, Qiao L. Potential epigenetic mechanism in non-alcoholic fatty liver disease. Int J Mol Sci. 2015;16:5161\u201379.","journal-title":"Int J Mol Sci"},{"key":"571_CR4","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.jep.2015.02.003","volume":"164","author":"A Tariq","year":"2015","unstructured":"Tariq A, Mussarat S, Adnan M. Review on ethnomedicinal, phytochemical and pharmacological evidence of Himalayan anticancer plants. J Ethnopharmacol. 2015;164:96\u2013119.","journal-title":"J Ethnopharmacol"},{"key":"571_CR5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.4196\/kjpp.2014.18.1.33","volume":"18","author":"WJ Choi","year":"2014","unstructured":"Choi WJ, Kim SK, Park HK, Sohn UD, Kim W. Anti-inflammatory and anti-superbacterial properties of sulforaphane from shepherd\u2019s purse. Korean J Physiol Pharmacol. 2014;18:33\u20139.","journal-title":"Korean J Physiol Pharmacol"},{"key":"571_CR6","first-page":"69","volume":"30","author":"Y-H Lee","year":"2012","unstructured":"Lee Y-H, Kwak J, Choi H-K, Choi K-C, Kim S, Lee J, et al. EGCG suppresses prostate cancer cell growth modulating acetylation of androgen receptor by anti-histone acetyltransferase activity. Int J Mol Med. 2012;30:69\u201374.","journal-title":"Int J Mol Med"},{"key":"571_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pharmthera.2012.11.002","volume":"138","author":"S Shankar","year":"2013","unstructured":"Shankar S, Kumar D, Srivastava RK. Epigenetic modifications by dietary phytochemicals: implications for personalized nutrition. Pharmacol Ther. 2013;138:1\u201317.","journal-title":"Pharmacol Ther"},{"key":"571_CR8","doi-asserted-by":"publisher","first-page":"26169","DOI":"10.1074\/jbc.M803544200","volume":"283","author":"G-L Wang","year":"2008","unstructured":"Wang G-L, Salisbury E, Shi X, Timchenko L, Medrano EE, Timchenko NA. HDAC1 cooperates with C\/EBP\u03b1 in the inhibition of liver proliferation in old mice. J Biol Chem. 2008;283:26169\u201378.","journal-title":"J Biol Chem"},{"key":"571_CR9","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1093\/jn\/138.9.1677","volume":"138","author":"M Bose","year":"2008","unstructured":"Bose M, Lambert JD, Ju J, Reuhl KR, Shapses SA, Yang CS. The major green tea polyphenol,(-)-epigallocatechin-3-gallate, inhibits obesity, metabolic syndrome, and fatty liver disease in high-fat\u2013fed mice. J Nutr. 2008;138:1677\u201383.","journal-title":"J Nutr"},{"key":"571_CR10","doi-asserted-by":"publisher","first-page":"11862","DOI":"10.1021\/jf2029016","volume":"59","author":"Y-K Chen","year":"2011","unstructured":"Chen YK, Cheung C, Reuhl KR, Liu AB, Lee MJ, Lu YP, et al. Effects of green tea polyphenol (\u2212)-epigallocatechin-3-gallate on newly developed high-fat\/western-style diet-induced obesity and metabolic syndrome in mice. J Agric Food Chem. 2011;59:11862\u201371.","journal-title":"J Agric Food Chem"},{"key":"571_CR11","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.molmet.2018.11.001","volume":"19","author":"M-Y Chung","year":"2019","unstructured":"Chung MY, Song JH, Lee J, Shin EJ, Park JH, Lee SH, et al. Tannic acid, a novel histone acetyltransferase inhibitor, prevents non-alcoholic fatty liver disease both in vivo and in vitro model. Mol Metab. 2019;19:34\u201348.","journal-title":"Mol Metab"},{"key":"571_CR12","doi-asserted-by":"publisher","first-page":"R25","DOI":"10.1530\/JOE-13-0201","volume":"218","author":"M Asrih","year":"2013","unstructured":"Asrih M, Jornayvaz FR. Inflammation as a potential link between nonalcoholic fatty liver disease and insulin resistance. J Endocrinol. 2013;218:R25\u201336.","journal-title":"J Endocrinol"},{"key":"571_CR13","doi-asserted-by":"publisher","first-page":"387","DOI":"10.3390\/nu9040387","volume":"9","author":"H Kitade","year":"2017","unstructured":"Kitade H, Chen G, Ni Y, Ota T. Nonalcoholic fatty liver disease and insulin resistance: new insights and potential new treatments. Nutrients. 2017;9:387.","journal-title":"Nutrients"},{"key":"571_CR14","doi-asserted-by":"publisher","first-page":"1900043","DOI":"10.1002\/mnfr.201900043","volume":"63","author":"Z Li","year":"2019","unstructured":"Li Z, Li Y, Zhang HX, Guo JR, Lam CWK, Wang CY, et al. Mitochondria\u2010mediated pathogenesis and therapeutics for non\u2010alcoholic fatty liver disease. Mol Nutr Food Res. 2019;63:1900043.","journal-title":"Mol Nutr Food Res"},{"key":"571_CR15","doi-asserted-by":"crossref","unstructured":"Masarone M, Rosato V, Dallio M, Gravina AG, Aglitti A, Loguercio C, et al. Role of oxidative stress in pathophysiology of nonalcoholic fatty liver disease. Oxid Med Cell Longev. 2018;2018:7864316.","DOI":"10.1155\/2018\/9547613"},{"key":"571_CR16","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.biocel.2017.12.019","volume":"95","author":"IC Sim\u00f5es","year":"2018","unstructured":"Sim\u00f5es IC, Fontes A, Pinton P, Zischka H, Wieckowski MR. Mitochondria in non-alcoholic fatty liver disease. Int J Biochem Cell Biol. 2018;95:93\u20139.","journal-title":"Int J Biochem Cell Biol"},{"key":"571_CR17","first-page":"59","volume":"14","author":"NA Al-Dhabi","year":"2015","unstructured":"Al-Dhabi NA, Arasu MV, Park CH, Park SU. An up-to-date review of rutin and its biological and pharmacological activities. EXCLI J. 2015;14:59\u201363.","journal-title":"EXCLI J"},{"key":"571_CR18","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1517\/13543784.2013.805744","volume":"22","author":"S Sharma","year":"2013","unstructured":"Sharma S, Ali A, Ali J, Sahni JK, Baboota S. Rutin: therapeutic potential and recent advances in drug delivery. Expert Opin Investig Drugs. 2013;22:1063\u201379.","journal-title":"Expert Opin Investig Drugs"},{"key":"571_CR19","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1080\/10715760600771400","volume":"40","author":"IB Jaganath","year":"2006","unstructured":"Jaganath IB, Jaganath IB, Mullen W, Edwards CA, Crozier A. The relative contribution of the small and large intestine to the absorption and metabolism of rutin in man. Free Radic Res. 2006;40:1035\u201346.","journal-title":"Free Radic Res"},{"key":"571_CR20","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1472-6882-14-21","volume":"14","author":"K-Y Su","year":"2014","unstructured":"Su KY, Yu CY, Chen YP, Hua KF, Chen YLS. 3, 4-Dihydroxytoluene, a metabolite of rutin, inhibits inflammatory responses in lipopolysaccharide-activated macrophages by reducing the activation of NF-\u03baB signaling. BMC Complement Alter Med. 2014;14:21.","journal-title":"BMC Complement Alter Med"},{"key":"571_CR21","doi-asserted-by":"crossref","unstructured":"Morales AM, Mukai R, Murota K, Terao J. Inhibitory effect of catecholic colonic metabolites of rutin on fatty acid hydroperoxide and hemoglobin dependent lipid peroxidation in Caco-2 cells. J Clin Biochem Nutr.\u00a02018;63:175\u201380.","DOI":"10.3164\/jcbn.18-38"},{"key":"571_CR22","doi-asserted-by":"publisher","first-page":"1600475","DOI":"10.1002\/mnfr.201600475","volume":"61","author":"JA Gim\u00e9nez\u2010Bastida","year":"2017","unstructured":"Gim\u00e9nez\u2010Bastida JA, Zielinski H, Piskula M, Zielinska D, Szawara\u2010Nowak D. Buckwheat bioactive compounds, their derived phenolic metabolites and their health benefits. Mol Nutr Food Res. 2017;61:1600475.","journal-title":"Mol Nutr Food Res"},{"key":"571_CR23","doi-asserted-by":"publisher","first-page":"21984","DOI":"10.1073\/pnas.0910040106","volume":"106","author":"B Lomenick","year":"2009","unstructured":"Lomenick B, Hao R, Jonai N, Chin RM, Aghajan M, Warburton S, et al. Target identification using drug affinity responsive target stability (DARTS). Proc Natl Acad Sci U S A. 2009;106:21984\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"571_CR24","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1002\/pro.2711","volume":"24","author":"R Sharma","year":"2015","unstructured":"Sharma R, Zhou MM. Partners in crime: The role of tandem modules in gene transcription. Protein Sci. 2015;24:1347\u201359.","journal-title":"Protein Sci"},{"key":"571_CR25","doi-asserted-by":"publisher","first-page":"W623","DOI":"10.1093\/nar\/gkp456","volume":"37","author":"Y Wang","year":"2009","unstructured":"Wang Y, Xiao J, Suzek TO, Zhang J, Wang J, Bryant SH. PubChem: a public information system for analyzing bioactivities of small molecules. Nucleic Acids Res. 2009;37:W623\u201333.","journal-title":"Nucleic Acids Res"},{"key":"571_CR26","doi-asserted-by":"publisher","first-page":"3876","DOI":"10.1128\/MCB.21.12.3876-3887.2001","volume":"21","author":"ET Manning","year":"2001","unstructured":"Manning ET, Ikehara T, Ito T, Kadonaga JT, Kraus WL. p300 forms a stable, template-committed complex with chromatin: role for the bromodomain. Mol Cell Biol. 2001;21:3876\u201387.","journal-title":"Mol Cell Biol"},{"key":"571_CR27","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1002\/biof.1154","volume":"40","author":"RP da Silva","year":"2014","unstructured":"da Silva RP, Kelly KB, Al Rajabi A, Jacobs RL. Novel insights on interactions between folate and lipid metabolism. Biofactors. 2014;40:277\u201383.","journal-title":"Biofactors."},{"key":"571_CR28","doi-asserted-by":"publisher","first-page":"5560","DOI":"10.1073\/pnas.091016398","volume":"98","author":"SC Lu","year":"2001","unstructured":"Lu SC, Alvarez L, Huang Z-Z, Chen L, An W, Corrales FJ, et al. Methionine adenosyltransferase 1A knockout mice are predisposed to liver injury and exhibit increased expression of genes involved in proliferation. Proc Natl Acad Sci U S A. 2001;98:5560\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"571_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-019-0702-5","volume":"11","author":"MC Sinton","year":"2019","unstructured":"Sinton MC, Hay DC, Drake AJ. Metabolic control of gene transcription in non-alcoholic fatty liver disease: the role of the epigenome. Clin Epigenet. 2019;11:104.","journal-title":"Clin Epigenet"},{"key":"571_CR30","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1126\/science.1198125","volume":"331","author":"D Feng","year":"2011","unstructured":"Feng D, Liu T, Sun Z, Bugge A, Mullican SE, Alenghat T, et al. A circadian rhythm orchestrated by histone deacetylase 3 controls hepatic lipid metabolism. Science. 2011;331:1315\u20139.","journal-title":"Science"},{"key":"571_CR31","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1111\/febs.12806","volume":"281","author":"DM Ferreira","year":"2014","unstructured":"Ferreira DM, Sim\u00e3o AL, Rodrigues CM, Castro RE. Revisiting the metabolic syndrome and paving the way for micro RNA s in non\u2010alcoholic fatty liver disease. FEBS J. 2014;281:2503\u201324.","journal-title":"FEBS J"},{"key":"571_CR32","doi-asserted-by":"publisher","first-page":"5443","DOI":"10.3390\/nu7075230","volume":"7","author":"S Legeay","year":"2015","unstructured":"Legeay S, Rodier M, Fillon L, Faure S, Clere N. Epigallocatechin gallate: a review of its beneficial properties to prevent metabolic syndrome. Nutrients. 2015;7:5443\u201368.","journal-title":"Nutrients"},{"key":"571_CR33","doi-asserted-by":"crossref","unstructured":"Shanak S, Saad B, Zaid H. Metabolic and epigenetic action mechanisms of antidiabetic medicinal plants.\u00a0Evid Based Complement Alternat Med. 2019;2019:3583067.","DOI":"10.1155\/2019\/3583067"},{"key":"571_CR34","doi-asserted-by":"publisher","first-page":"19134","DOI":"10.1074\/jbc.M301580200","volume":"278","author":"K Balasubramanyam","year":"2003","unstructured":"Balasubramanyam K, Swaminathan V, Ranganathan A, Kundu TK. Small molecule modulators of histone acetyltransferase p300. J Biol Chem. 2003;278:19134\u201340.","journal-title":"J Biol Chem"},{"key":"571_CR35","doi-asserted-by":"publisher","first-page":"169","DOI":"10.2174\/157340606776056133","volume":"2","author":"MG Marcu","year":"2006","unstructured":"Marcu MG, Jung YJ, Lee S, Chung EJ, Lee MJ, Trepel J, et al. Curcumin is an inhibitor of p300 histone acetylatransferase. Med Chem. 2006;2:169\u201374.","journal-title":"Med Chem"},{"key":"571_CR36","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1126\/science.1179689","volume":"327","author":"S Zhao","year":"2010","unstructured":"Zhao S, Xu W, Jiang W, Yu W, Lin Y, Zhang T, et al. Regulation of cellular metabolism by protein lysine acetylation. Science. 2010;327:1000\u20134.","journal-title":"Science"},{"key":"571_CR37","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1677\/JME-08-0025","volume":"41","author":"KM Aagaard-Tillery","year":"2008","unstructured":"Aagaard-Tillery KM, Grove K, Bishop J, Ke X, Fu Q, McKnight R, et al. Developmental origins of disease and determinants of chromatin structure: maternal diet modifies the primate fetal epigenome. J Mol Endocrinol. 2008;41:91\u2013102.","journal-title":"J Mol Endocrinol"},{"key":"571_CR38","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1002\/jat.3502","volume":"37","author":"NE De Long","year":"2017","unstructured":"De Long NE, Hardy DB, Ma N, Holloway AC. Increased incidence of non\u2010alcoholic fatty liver disease in male rat offspring exposed to fluoxetine during fetal and neonatal life involves the NLRP3 inflammasome and augmented de novo hepatic lipogenesis. J Appl Toxicol. 2017;37:1507\u201316.","journal-title":"J Appl Toxicol"},{"key":"571_CR39","doi-asserted-by":"publisher","first-page":"196","DOI":"10.4162\/nrp.2019.13.3.196","volume":"13","author":"S Chung","year":"2019","unstructured":"Chung S, Hwang JT, Park JH, Choi HK. Free fatty acid-induced histone acetyltransferase activity accelerates lipid accumulation in HepG2 cells. Nutr Res Pr. 2019;13:196\u2013204.","journal-title":"Nutr Res Pr"},{"key":"571_CR40","doi-asserted-by":"publisher","first-page":"7681","DOI":"10.1074\/jbc.274.12.7681","volume":"274","author":"L Gelman","year":"1999","unstructured":"Gelman L, Zhou G, Fajas L, Rasp\u00e9 E, Fruchart JC, Auwerx J. p300 interacts with the N-and C-terminal part of PPAR\u03b32 in a ligand-independent and-dependent manner, respectively. J Biol Chem. 1999;274:7681\u20138.","journal-title":"J Biol Chem"},{"key":"571_CR41","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1128\/MCB.23.7.2587-2599.2003","volume":"23","author":"V Giandomenico","year":"2003","unstructured":"Giandomenico V, Simonsson M, Gr\u00f6nroos E, Ericsson J. Coactivator-dependent acetylation stabilizes members of the SREBP family of transcription factors. Mol Cell Biol. 2003;23:2587\u201399.","journal-title":"Mol Cell Biol"},{"key":"571_CR42","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.semcancer.2013.08.010","volume":"23","author":"Y Tian","year":"2013","unstructured":"Tian Y, Wong VWS, Chan HLY, Cheng ASL. Epigenetic regulation of hepatocellular carcinoma in non-alcoholic fatty liver disease. Semin Cancer Biol 2013;23:471\u201382.","journal-title":"Semin Cancer Biol"},{"key":"571_CR43","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1021\/bi500380f","volume":"53","author":"J Maksimoska","year":"2014","unstructured":"Maksimoska J, Segura-Pen\u0303a D, Cole PA, Marmorstein R. Structure of the p300 histone acetyltransferase bound to acetyl-coenzyme A and its analogues. Biochemistry. 2014;53:3415\u201322.","journal-title":"Biochemistry"},{"key":"571_CR44","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1038\/nsmb.2642","volume":"20","author":"M Delvecchio","year":"2013","unstructured":"Delvecchio M, Gaucher J, Aguilar-Gurrieri C, Ortega E, Panne D. Structure of the p300 catalytic core and implications for chromatin targeting and HAT regulation. Nat Struct Mol Biol. 2013;20:1040\u20136.","journal-title":"Nat Struct Mol Biol"},{"key":"571_CR45","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/s41573-019-0030-7","volume":"18","author":"AG Cochran","year":"2019","unstructured":"Cochran AG, Conery AR, Sims RJ. Bromodomains: a new target class for drug development. Nat Rev Drug Discov. 2019;18:609\u201328.","journal-title":"Nat Rev Drug Discov"},{"key":"571_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/srep34441","volume":"6","author":"L Chang","year":"2016","unstructured":"Chang L, Takada S. Histone acetylation dependent energy landscapes in tri-nucleosome revealed by residue-resolved molecular simulations. Sci Rep. 2016;6:34441.","journal-title":"Sci Rep"},{"key":"571_CR47","doi-asserted-by":"publisher","first-page":"4179","DOI":"10.1021\/acs.analchem.6b00400","volume":"88","author":"F Zhang","year":"2016","unstructured":"Zhang F, Huang Q, Yan J, Chen Z. Histone acetylation induced transformation of B-DNA to Z-DNA in cells probed through FT-IR spectroscopy. Anal Chem. 2016;88:4179\u201382.","journal-title":"Anal Chem"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-020-00571-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-020-00571-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-020-00571-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T05:11:56Z","timestamp":1629436316000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-020-00571-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,10]]},"references-count":47,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["571"],"URL":"https:\/\/doi.org\/10.1038\/s41401-020-00571-7","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,10]]},"assertion":[{"value":"24 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}